(2/25/26) NIH grant will investigate cause of a body malformation called hypospadias. Hypospadias is the second most common birth defect in males – affecting about
...
(2/17/26) The clinical trial marks the latest human trial at Mizzou involving radioisotopes to treat cancer.
...
(1/28/26) Cardiovascular disease continues to be the leading cause of death worldwide. To save lives
...
Awards and Honors
Bresette places first at EQ competition, earns $15,000 prize
(11/25/25) Nathan Bresette’s venture “RgentAI” won Mizzou’s EQ competition, earning $15K to grow his AI
...
Awards and Honors
Bresette and School of Medicine excel at EQ competition
(11/17/25) MU PhD student Nathan Bresette pitched “RgentAI,” an AI-powered RStudio assistant for smarter coding
...
(6/10/25) A project funded by Veterans Affairs will study if common medication can improve health
...
(3/27/25) A new study by researchers from Marshall University and the University of Missouri highlights
...
(2/7/25) Low-density lipoproteins (LDL) — commonly known as bad cholesterol — have long been on
...